Thursday, June 19th, 2025
Stock Profile: AXDX

Accelerate Diagnostics, Inc. (AXDX)

Market: NASD | Currency: USD

Address: 3950 South Country Club Road

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Show more




📈 Accelerate Diagnostics, Inc. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2023 - $0.100000 - 2023-07-12 - Stock split
Total Amount for 2023: $0.100000


📅 Earnings & EPS History for Accelerate Diagnostics, Inc.


DateReported EPS
2026-03-19 (estimated upcoming)-
2025-11-05 (estimated upcoming)-
2025-08-06 (estimated upcoming)-
2025-05-06-
2025-03-21-0.38
2025-01-10-
2024-11-07-0.59
2024-08-08-0.53
2024-05-08-0.88
2024-03-29-0.81
2023-11-090.14
2023-08-10-1.31
2023-05-11-0.17
2023-03-29-0.14
2022-11-14-0.18
2022-08-15-0.23
2022-05-16-0.21
2022-03-08-0.35
2021-11-09-0.15
2021-08-05-0.36
2021-05-06-0.41
2021-02-23-0.33
2020-11-05-0.33
2020-08-06-0.35
2020-05-07-0.39




📰 Related News & Research


No related articles found for "accelerate diagnostics".